Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048763
Status:
COMPLETED
Last Update Posted:
2005-07-19
First Post:
2002-11-07
Brief Title:
Safety and Efficacy of PletalCilostazol for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon
Sponsor:
Otsuka America Pharmaceutical
Organization:
Otsuka America Pharmaceutical
Organization Data
Organization:
Otsuka America Pharmaceutical
Class:
INDUSTRY
Study ID:
21-01-335
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Otsuka America Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None